Evidence map›Paper›PMID 40894567›Full record

ArticlebioRxiv : the preprint server for biology2025

From sequence to scaffold: computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks.

Cyrus M Haas, Naveen Jasti, Annie Dosey, Joel D Allen, Rebecca Gillespie, Jackson McGowan, Elizabeth M Leaf, Max Crispin, Cole A DeForest, Masaru Kanekiyo and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Cyrus M HaasDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-2204-9847
Naveen JastiInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Annie DoseyInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Joel D AllenSchool of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.ORCID 0000-0003-2547-968X
Rebecca GillespieVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892.
Jackson McGowanInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Elizabeth M LeafInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Max CrispinSchool of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.ORCID 0000-0002-1072-2694
Cole A DeForestDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-0337-3577
Masaru KanekiyoVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892.
Neil P KingInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Structure-based design of broadly protective coronavirus vaccinesP01AI167966 · NIAID · UNIVERSITY OF WASHINGTON · PI Neil King, David Veesler · 2022 to 2026
$15.3M
University of Washington Medical Scientist Training ProgramT32GM153182 · NIGMS · UNIVERSITY OF WASHINGTON · PI MARSHALL S. HORWITZ · 2024 to 2026
$5.3M
Gates Foundation INV-008813Gates Foundation INV-010680NIAID NIH HHS P01 AI167966NIGMS NIH HHS T32 GM007266NIGMS NIH HHS T32 GM153182
6 · The paper itself

Abstract

Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to novel nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing new self-assembling proteins have been established, the recent development of powerful machine learning-based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing novel self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six new 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryo-electron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor binding domain through a rigid

Indexed as

Biochemistry (minor)Biological Sciences (major)influenzananoparticlesprotein designvaccines

Identifiers

PMID40894567
PMCPMC12393622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.